201 related articles for article (PubMed ID: 27788486)
1. GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.
Pei Y; Yao Q; Yuan S; Xie B; Liu Y; Ye C; Zhuo H
Oncotarget; 2016 Nov; 7(47):77890-77901. PubMed ID: 27788486
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
[TBL] [Abstract][Full Text] [Related]
3. KDM1A drives hepatoblastoma progression by activating the Wnt/β-catenin pathway through inhibition of DKK3 transcription.
Ji C; Chen L; Yuan M; Xie W; Sheng X; Yin Q
Tissue Cell; 2023 Apr; 81():101989. PubMed ID: 36642006
[TBL] [Abstract][Full Text] [Related]
4. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of
Liu L; Cui Z; Zhang J; Wang J; Gu S; Ma J; Chen H; Hang L; Yang J; Shi Y
Cancer Biother Radiopharm; 2020 Feb; 35(1):41-49. PubMed ID: 31916845
[No Abstract] [Full Text] [Related]
7. Downregulation of transcription factor GATA4 sensitizes human hepatoblastoma cells to doxorubicin-induced apoptosis.
Soini T; Pihlajoki M; Kyrönlahti A; Andersson LC; Wilson DB; Heikinheimo M
Tumour Biol; 2017 Mar; 39(3):1010428317695016. PubMed ID: 28349834
[TBL] [Abstract][Full Text] [Related]
8. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor GATA-4 is abundantly expressed in childhood but not in adult liver tumors.
Soini T; Haveri H; Elo JM; Kauppinen M; Kyrönlahti A; Salo MK; Lohi J; Andersson LC; Wilson DB; Heikinheimo M
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):101-8. PubMed ID: 21788913
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas.
Pei Y; Kano J; Iijima T; Morishita Y; Inadome Y; Noguchi M
Virchows Arch; 2009 Jun; 454(6):639-46. PubMed ID: 19437037
[TBL] [Abstract][Full Text] [Related]
11. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
[TBL] [Abstract][Full Text] [Related]
13. Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.
Jin J; Jin J; Woodfield SE; Patel RH; Jin NG; Shi Y; Liu B; Sun W; Chen X; Yu Y; Vasudevan SA
Oncol Rep; 2019 Jan; 41(1):143-153. PubMed ID: 30320362
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis.
Zhu C; He X; Chen K; Huang Z; Yao A; Tian X; You Y; Zeng M
Cell Cycle; 2021; 20(5-6):575-590. PubMed ID: 33651649
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
17. Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/β-Catenin Pathway.
Huo J; Zhang Y; Li R; Wang Y; Wu J; Zhang D
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801786
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients.
Wagner F; Henningsen B; Lederer C; Eichenmüller M; Gödeke J; Müller-Höcker J; von Schweinitz D; Kappler R
Eur J Cancer; 2012 Oct; 48(15):2442-50. PubMed ID: 22285179
[TBL] [Abstract][Full Text] [Related]
20. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
